Phase I/II study of transfection efficacy and safety of MetXia (OB83) in patients with cutaneous lesions of breast cancer

Project Details

Short titlePhase I/II study of transfection efficacy and safety of MetXia (OB83) in patients with cutaneous lesions of breast cancer
StatusFinished
Effective start/end date2/06/031/08/05

Funding

  • OXFORD BIOMEDICA LTD